Chengbo Wang

593 total citations
30 papers, 424 citations indexed

About

Chengbo Wang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Chengbo Wang has authored 30 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Immunology. Recurrent topics in Chengbo Wang's work include Liver Disease Diagnosis and Treatment (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Cancer-related molecular mechanisms research (3 papers). Chengbo Wang is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Cancer-related molecular mechanisms research (3 papers). Chengbo Wang collaborates with scholars based in China, Japan and United States. Chengbo Wang's co-authors include Yanwei Xing, Daxun Piao, Yuekun Zhu, Tao Jiang, Tiemin Zhang, Shuhan Yang, Yalan Tu, Jun Li, Yansong Dong and Yangyang Zhao and has published in prestigious journals such as Chemical Communications, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Chengbo Wang

27 papers receiving 417 citations

Peers

Chengbo Wang
Tobias Ackermann Netherlands
Hongxia Lin United States
Tobias Ackermann Netherlands
Chengbo Wang
Citations per year, relative to Chengbo Wang Chengbo Wang (= 1×) peers Tobias Ackermann

Countries citing papers authored by Chengbo Wang

Since Specialization
Citations

This map shows the geographic impact of Chengbo Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengbo Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengbo Wang more than expected).

Fields of papers citing papers by Chengbo Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengbo Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengbo Wang. The network helps show where Chengbo Wang may publish in the future.

Co-authorship network of co-authors of Chengbo Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Chengbo Wang. A scholar is included among the top collaborators of Chengbo Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengbo Wang. Chengbo Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Ning, Li Du, Lei Zhang, et al.. (2025). Portal hypertension contributes to ascites formation via the Piezo1−nuclear factor kappa-B−aquaporin1 pathway in liver cirrhosis. Experimental & Molecular Medicine. 57(10). 2305–2316.
2.
Liu, Yuchun, Kang Cheng, Cong Ding, et al.. (2024). UBD participates in neutrophilic asthma by promoting the activation of IL-17 signaling. International Journal of Biological Macromolecules. 264(Pt 1). 130581–130581. 1 indexed citations
4.
Wei, Ning, Chang Liu, Chengbo Wang, et al.. (2024). Hypoalbuminemia contributes to ascites formation via sodium and water retention: Evidence from clinical date and albumin deficient mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(6). 167275–167275. 3 indexed citations
5.
Zhang, Ying, Chun‐Yan Sang, Xingrong Wang, et al.. (2024). Rapid evaluation of PHD2 inhibitory activity of natural products based on capillary electrophoresis online stacking strategy. Journal of Chromatography B. 1236. 124064–124064. 1 indexed citations
6.
Komura, Masayuki, Chengbo Wang, Shunsuke Kato, et al.. (2024). Simultaneous Expression of CD70 and POSTN in Cancer-Associated Fibroblasts Predicts Worse Survival of Colorectal Cancer Patients. International Journal of Molecular Sciences. 25(5). 2537–2537. 4 indexed citations
7.
Cheng, Xiang, Ming Zhao, Tong Zhao, et al.. (2023). Gypenoside-14 Reduces Depression via Downregulation of the Nuclear Factor Kappa B (NF-kB) Signaling Pathway on the Lipopolysaccharide (LPS)-Induced Depression Model. Pharmaceuticals. 16(8). 1152–1152. 15 indexed citations
8.
Komura, Masayuki, Chengbo Wang, Kazuhiro Nagao, et al.. (2023). Stromal POSTN Enhances Motility of Both Cancer and Stromal Cells and Predicts Poor Survival in Colorectal Cancer. Cancers. 15(3). 606–606. 13 indexed citations
10.
Komura, Masayuki, Shunsuke Kato, Takahiro Otani, et al.. (2023). Characterization of colorectal cancer by hierarchical clustering analyses of five immune cell markers. Pathology International. 74(1). 13–25. 3 indexed citations
11.
Wang, Chengbo, et al.. (2023). Ferritinophagy‐mediated ferroptosis facilitates methotrexate‐induced hepatotoxicity by high‐mobility group box 1 ( HMGB1 ). Liver International. 44(3). 691–705. 19 indexed citations
13.
Zhao, Ming, Jun‐Li Yang, Xiang Cheng, et al.. (2022). GP-14 protects against severe hypoxia-induced neuronal injury through the AKT and ERK pathways and its induced transcriptome profiling alteration. Toxicology and Applied Pharmacology. 448. 116092–116092. 4 indexed citations
14.
Yang, Jun‐Li, Xiang Cheng, Ying Han, et al.. (2022). A bioactive gypenoside (GP-14) alleviates neuroinflammation and blood brain barrier (BBB) disruption by inhibiting the NF-κB signaling pathway in a mouse high-altitude cerebral edema (HACE) model. International Immunopharmacology. 107. 108675–108675. 36 indexed citations
15.
Yang, Siyu, Chengbo Wang, Liang Li, et al.. (2022). Single-Cell Characterization of Hepatic CD8+ T Cells in a Murine Model of Primary Biliary Cholangitis. Frontiers in Immunology. 13. 860311–860311. 10 indexed citations
16.
Wang, Chengbo, Yan Wang, Yuan Yao, et al.. (2022). The gut microbiome contributes to splenomegaly and tissue inflammation in a murine model of primary biliary cholangitis. Annals of Translational Medicine. 10(9). 507–507. 11 indexed citations
17.
Zhao, Zhibin, Chengbo Wang, Yang Li, et al.. (2022). High Dimensional Analysis of PBMC in Axial Spondyloarthritis Reveals that S100A8 <sup>hi</sup> Monocyte Derived CXCL8 Mediates Neutrophil Recruitment. SSRN Electronic Journal. 1 indexed citations
18.
Long, Jie, Chengbo Wang, Shuhan Yang, et al.. (2021). Characterization of Organ-Specific Regulatory B Cells Using Single-Cell RNA Sequencing. Frontiers in Immunology. 12. 711980–711980. 28 indexed citations
19.
Ren, Shuo, Yanwei Xing, Chengbo Wang, et al.. (2020). Fraxetin inhibits the growth of colon adenocarcinoma cells via the Janus kinase 2/signal transducer and activator of transcription 3 signalling pathway. The International Journal of Biochemistry & Cell Biology. 125. 105777–105777. 16 indexed citations
20.
Wang, Chengbo, Cong Ding, Juan Du, et al.. (2019). Protein 4.1B Suppresses Tumor Metastasis by Regulating Epithelial-mesenchymal Transition Progression in Melanoma Cells. International Journal of Medical Sciences. 16(4). 529–536. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026